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PPMI. PPMI defined as 3-fold increase in CK-MB or troponin-I after procedure and
patients initially diagnosed with MI excluded.
Results: In multivariate analysis, the independent predictors for PPMI after bifurcation
stenting were acute closure in side branch, unstable angina, more than 30mm in total
stent length of parent vessel (PV), left main or 3 vessel disease, and Taxus® in PV
(HR=4.177; 95% CI=1.993-8.756, HR=2.283; 95% CI=1.581-3.297; HR=1.035; 95%
CI=1.014-1.057, HR=1.759; 95% CI=1.220-2.535 and HR=1.717; 95% CI=1.194-
2.468 respectively). During 22-month follow-up, there was no difference in mortality
between PPMI and no PPMI group (96.3% vs. 98.7%, p=0.168). Propensity score-
adjusted Cox regression analysis showed that the PPMI was not an independent
predictor of mortality (adjusted HR 0.749; 95% CI 0.166 – 3.648, p=0.777).
Kaplan-Meier curves for long-term mortality among no PPMI group, those with CK-
MB or Tn-I increase 3 to 10 times, and with CK-MB or Tn-I increase ≥10 times
Conclusion: In the bifurcation stenting, although PPMI is still occurred frequently,
however, it isn’t significantly associated with long-term mortality.
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Background: The provisional approach has become the default strategy in bifurcation
PCI. However, there are some inherent limitations of the provisional approach
including the acceptance of a suboptimal result at the side branch (SB) and the risk of
SB compromise or even occlusion. A dedicated SB stent may overcome some of these
limitations of provisional stenting by facilitating the procedure. However, there are
limited data to support this approach
Methods: We performed a retrospective cross-sectional survey of the current practice
of provsional stenting for the bifurcation. The survey collected procedural data of 110
bifurcations most recently treated with a provsional approach in 4 centres. We then
compared these data with patients enrolled in the multi-centre European registry of
true bifurcations treated with Sideguard (Cappella Inc., Galway, Ireland) dedicated
side branch stent. The primary endpoint of the study was SB failure defined as: residual
SB stenosis≥50%; inability to re-access the SB after main branch (MB) treatment;
dissection of the SB; and need for cross-over to SB stenting.
Results: Almost all lesions treated were true bifurcations in both the provisional and
Sideguard groups (97% vs. 96%). Procedural success was high in both groups (97%
vs. 96%). In the provisional group, the SB was stented in 15% of cases and 22% had
a SB residual stenosis≥50% at the end of the procedure. The primary endpoint of SB
failure occurred significantly more frequently in the provisional group (33% vs. 5%;
p=0.01). Procedural (78±23 vs. 67±29 mins; p=NS) and flouroscopy time (21.2±8.9
vs. 22+/-5.5; p=NS) were similar in both groups.
Conclusion: SB ostial protection with the Sideguard device reduces SB failure in
comparison to provisional stenting without increasing procedural time. The Sideguard
dedicated bifurcation stent could facilitate bifurcation PCI and make the procedure
more predictable and safe. This approach requires further evaluation in a randomized
controlled trial.
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Background: Provisional stenting is now the default approach for treatment of
bifurcation lesions. It is however still controversial whether dilatation of the Side
Branch (SB) after Main Vessel (MV) stenting is beneficial and when Kissing Balloon
(KB) inflation should be performed.
Methods: Optimisation using final KB technique was compared with a simpler
sequential 2 step SB-MV dilatation without kiss in a series of drug eluting stents (n=26)
delivered in a bench model of a representative coronary bifurcation. Stent apposition
and stent area was quantified at different locations along the MV from micro-CT scans.
Vessel wall stresses and detailed reconstruction of blood flow patterns were obtained
in the model using Finite Element Analysis (FEA) and Computational Fluid Dynamics
(CFD).
Results: SB ostial stenosis was on average 20.9 ± 8.7 % after KB and 25.6 ± 11.6 %
after 2-Step sequential optimization (p=0.25, ns) compared to 69.2 ± 7.8 % without
SB dilatation, p<0.0001. Differences were observed between the stent platforms with
CoCr and PtCr stents producing higher ostial stenosis than SS based platforms
(respectively 27.3 ± 8.5% and 20.0 ± 10.2%, p=0.06). KB induced a significant
asymmetric expansion of the lumen proximal to the SB and led to a higher risk of
incomplete stent apposition at the proximal stent edge (36.4 ± 29.8 % vs. 3.8 ± 10.1 %
for 2-step, p=0.0016). SB dilatation alone without further MV post-dilatation is
associated distortion of the stent at the MV ostium, resulting in a high risk of stent
malapposition opposite the SB. Rate of malapposition in the bifurcation after KB and
2-Step was respectively 22.1 ± 8.9 % and 26.6 ± 8.9 %, a significant reduction
compared to SB dilatation (55.3 ± 16.8 %, p<0.0001) or MV stenting only (47.0 ± 8.5
%, p<0.0005).
Conclusion: Sequential 2-step post-dilatation of the SB and MV may be a suitable
alternative to final Kissing Balloon Inflation after provisional stenting of bifurcations.
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Background: Treatment of coronary bifurcation lesion by drug eluting stent (DES)
reduced the restenosis and major adverse cardiac events compared to by bare metal
stent (BMS). Several study evaluated the tissue formation on the jailed strut at follow-
up term post-DES implant by OCT. The serial change of jailed struts at long-term after
implantation has not been clarified. The aim of this study was to evaluate serial change
of tissue formation at bifurcation lesions.
Methods: 20 true coronary bifurcation lesions treated with sirolimus eluting stent
(SES) were analyzed by serial optical coherence tomography (OCT) follow-up at 6
month and very late phase (43 to 73 months). We evaluated stent apposition and
coverage of neointimal tissue on the strut. Thickness of neointima were measured for
apposed strut, jailed strut and thickness of tissue surrounding jailed strut. The change
of thrombus formation was also assessed.
Results: Neointimal thickness of non-jailed (well-apposed) strut increased from 6-
month to very late phase, and on jailed strut, both neointimal tissue thickness
(67.0±49.2 to 114.0±64.9μm, P<0.05) and whole tissue thickness (332.0±165.8 to
430.7±138.3μm, P<0.05) increased. %uncovered strut at bifurcation lesion were
decreased (7.5±7.7% to 4.1±5.6%, P<0.05). The frequency of thrombus on jailed struts
at 6 months were 40% (8/20) lesions, which disappeared at very late phase.
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Conclusion: Serial OCT follow-up revealed delayed tissue coverage onto both jailed
and non-jailed strut and resolution of thrombus attachment, suggesting long-term safety
of SES implantation to bifurcation lesion.
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Background: Though drug-eluting stents have dramatically improved the clinical
outcomes, percutaneous intervention for left main trunk (LMT) distal bifurcation
lesions is still challenging because of high rate of target lesion revascularization (TLR),
stent thrombosis (ST) and mortality. Recently, superiority of provisional single-stent
strategy for bifurcation lesions has been reported, however, long-term efficacy of this
approach for LMT distal bifurcation is unclear.
Methods: Eighty four consecutive patients underwent LMT distal bifurcation stenting
by scheduled provisional single-stent strategy in a single center. Sirolimus-eluting
stents were deployed in all the cases. PCI were avoided whatever possible if the lesion
had inappropriate plaque distribution for this strategy (mainly involving complex LCx
ostial disease). In all the cases, intravascular ultrasound guided procedure were
performed. Major adverse cardiac events (MACE), TLR, cardiac death, and ST were
evaluated during the follow-up period (mean 35 months).
Results: In sixty one patients (72%) final kissing balloon technique was performed,
and three (3.6%) received additional stenting (all provisional T stenting). Prevalence
of 1 year, 2 years and 3 years MACE were 6.1%, 8.9% and 13.6%, respectively. TLR
and Cardiac death occurred at 3 years were 8.0% and 1.2%, respectively. There were
no ST events during follow-up period.
Conclusion: Even though LMT distal bifurcation disease, provisional single stent
strategy for feasible lesions showed favorable long-term clinical outcomes.
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Background: Coronary bifurcation percutaneous treatment represents a special
coronary artery disease subset. Various techniques are been used treating these lesions,
but few data are available regarding “true” bifurcation lesions (Medina 1,1,1).
Methods: We evaluated major adverse cardiovascular events (MACE) trend in a
nation-wide retrospective registry of patients that underwent coronary bifurcation
percutaneous treatment, comparing provisional stenting technique versus both branches
PCI.
Results: We enrolled 2447 patients, with a mean follow up of 32 months (±16). 1271
were assigned to provisional group (PG, 52% of cases) and both branches PCI (BB).
Mean age was 64 years ±12 (p=0,7), LVEF 53% (p=0,4), diabetes was present in 38%
and 35% (p=0,4), chronic kidney disease in 9,7% (p=0,6). Multivessel disease
interested 39% and 36% (p=0,3) of patients. 4,6% of PCI were performed due
bifurcation restenosis in PG instead 7,6% in BB group (p=0,002). 17% of PG patients
underwent PCI due acute coronary syndrome in front of 11% of BB patients (p<0,001).
Double antiplatelet therapy duration was significantly shorter in PG (8,5 months vs
11, p<0,001) and DES usage was less represented (37% vs 43%, p<0,001). Stent
thrombosis was equally represented in the two groups (1,5% vs 2,8%, p=0,3). At
univariate analysis, PG is related to better survival free from MACE (p<0,002) and
similar overall survival (p=0,8). At Cox regression, DES usage is independently related
to greater free from mace survival (95% CI HR 0,6-0,9, p=0,04). On other hand,
restenosis as indication for PCI is a MACE predictor (95% CI HR 1,6-2,8, p<0,001).
In this setting, no differences are detected between provisional stenting and both
branches PCI.
Conclusion: Despite the complex lesion subset of true bifurcations, single stent use
(provisional approach) is related to better results in term of TLR and MACE, with
similar overall survival at middle term follow up, even after double antiplatelet per
protocol discontinuation.
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Background: Left main percutaneous coronary intervention has increased in Spain.
However, there is limited data about the outcome of these patients.
Methods: Multicentered observational, prospective registry, that included all
consecutive patients with severe left main coronary artery (LMCA) disease treated
percutaneously at 30 centers We describe patient and procedure characteristics and
follow-up at 6 and 12 months.
Results: Between 2007 and 2008, 782 patients were enrolled. 74.6% were men, mean
age was 70.8 ± 11.1 years, 41.9% were diabetic. Main indications for PCI were unstable
angina/NSTEMI in 49.8% and STEMI in 11.3%. A 7% had cardiogenic shock. 54.5%
were distal LMCA lesions, and 46.3% had both branch ostia involvement. Mean
stenosis was 74.2±15.4%, being calcified lesions 50.3%. IVUS was used in 24.8%.
86% was treated with a single stent approach, 43.4% limited to LM and 41.5%
extending to the LAD. When a 2-stent-technique was used, the crush stenting technique
was the preferred. DES was used in 79,9% . The success rate was 96.4%. In-hospital
mortality was 2.3%, excluding patients with cardiogenic shock and STEMI at
presentation. Follow-up at 6 months: 13% patients had angina or ischemia. At 12
months 15.1% patients had to be admitted to hospital, mainly due to angina or
myocardial infarction. Clinical restenosis rate was 2.5% confined to LM, 17.9% in the
ostium of the circumflex and 13.5% in the ostium of the LAD. MACE was 27.2%
(including those patients with cardiogenic shock and myocardial infarction at baseline).
Multivariate logistic regression analysis showed as independent risk factors for new
revascularization a technique with more than one stent implanted, and left circumflex
ostium involvement
Conclusion: PCI in LMCA in Spain is performed mainly in complex lesions, with a
very low mortality in patients without cardiogenic shock. A single stent approach is
the preferred technique. Among patients with distal LMCA lesions, left circumflex
ostium involvement and a technique that used more than one stent were associated
with a higher rate of repeat revascularization.
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